Proteinuria in Pre and Post Transplant
ConditionProteinuria
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 25
SponsorUniversity of Miami
About this trial
Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Kidney transplant recipients
Pediatric males and females up to the age of 25 years old.
Disqualifiers
Transplant recipients other than kidney
Trial population
Pediatric population up to the age of 25 years old, with biopsy diagnosed of FSGS (focal segmental glomerulosclerosis).
Trial design
Design model
Other
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Explain mechanisms behind the development of proteinuria in patients immediately after receiving a kidney transplant
chart review
Time frame
through study completion, an average of 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov